secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemomab Therapeutics Ltd. (CMMB)
CIK:        0001534248
Form:       8-K
Filed at:   2023-01-11T23:59:59+00:00
Accession:  0001178913-23-000147
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemomab Therapeutics furnishes updated corporate presentation; no specific facts available from filing text
--------------------------------------------------------------------------------

- Chemomab Therapeutics filed an updated corporate presentation on January 11, 2023.
- The presentation is intended for investor and analyst use; no financial results or material events were announced.
- No further details from the presentation are included in the filing text provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534248/000117891323000147/0001178913-23-000147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534248/000117891323000147/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001178913-23-000147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer